Improved survival outcomes and restoration of graft‐vs‐leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia

Deferasirox is an oral iron‐chelating agent having possible antileukemia and immune modulatory effects. Few reports have evaluated deferasirox in the setting of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). We investigated the impact of deferasirox after allo‐HSCT in acute myeloid...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Med
Egile Nagusiak: Cho, Byung‐Sik, Jeon, Young‐Woo, Hahn, A‐Reum, Lee, Tai‐Hyang, Park, Sung‐Soo, Yoon, Jae‐Ho, Lee, Sung‐Eun, Eom, Ki‐Seong, Kim, Yoo‐Jin, Lee, Seok, Min, Chang‐Ki, Cho, Seok‐Goo, Lee, Jong‐Wook, Min, Woo‐Sung, Kim, Hee‐Je
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2019
Gaiak:
Clinical Cancer Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6382990/
https://ncbi.nlm.nih.gov/pubmed/30677244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1928
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak